The effect of contraceptive DE on the endometrial preparation in hysteroscopic polypectomy

Phase 2

• Conditions: terine polyp.; Polyp of cervix uteri; N84.1

• Registration Number: IRCT20200825048515N28
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 April 2021

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

The ages of premenopause (30-45 year)
Body mass index (BMI) between 23 and 28 kg/m2
Parity of 0-3
Polyps less than 2.5 cm

Exclusion Criteria

Contraindication of receiving Oral contraceptive (OCP)
Undertreatment with hormonal drugs over the last 8 weeks (before enrollment)
Having uterine and adnexal diseases including cervical and endometrial cancers
Having active cervicitis and pelvic infection
Having diabetes or thyroid disease

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Endometrial thickness. Timepoint: Before taking the contraceptive DE and the day before surgery. Method of measurement: Transvaginal ultrasound.